| FDA advisory panel recommends darbepoetin alpha remain on market - Cardiology Today |
|
|
Cardiology TodayThe Cardiovascular and Renal Drugs Advisory Committee voted 15 to 1 to recommend keeping darbepoetin on the market, despite an increased risk for stroke ... read more |